Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
117M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
51.6M
-
Shares change
-
-3.72M
-
Total reported value, excl. options
-
$84.5M
-
Value change
-
-$2.98M
-
Put/Call ratio
-
0.41
-
Number of buys
-
52
-
Number of sells
-
-47
-
Price
-
$1.64
Significant Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2025
130 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.6M shares
of 117M outstanding shares and own 44.09% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (10.5M shares), VANGUARD GROUP INC (10.3M shares), TANG CAPITAL MANAGEMENT LLC (5.1M shares), Kohlberg Kravis Roberts & Co. L.P. (3.04M shares), GEODE CAPITAL MANAGEMENT, LLC (2.74M shares), STATE STREET CORP (2.22M shares), CM Management, LLC (2.1M shares), C WorldWide Group Holding A/S (1.93M shares), PANAGORA ASSET MANAGEMENT INC (1.38M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (993K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.